IceCure Medical Ltd. Closes Rights Offering
Ticker: ICCM · Form: 6-K · Filed: Aug 1, 2025 · CIK: 1584371
Sentiment: neutral
Topics: rights-offering, capital-raise, foreign-private-issuer
TL;DR
IceCure Medical closed its rights offering on Aug 1st after the subscription period ended July 28th.
AI Summary
IceCure Medical Ltd. announced the closing of its Rights Offering on August 1, 2025. The subscription period for this offering expired on July 28, 2025, at 5:00 p.m. Eastern Time. The company is a foreign private issuer based in Israel.
Why It Matters
The closing of a rights offering indicates the company has successfully raised capital, which can be used for operations, expansion, or debt reduction.
Risk Assessment
Risk Level: low — This filing is a routine report of a completed corporate action (rights offering closing) and does not introduce new risks.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- July 28, 2025 (date) — Expiration of Subscription Period
- August 1, 2025 (date) — Closing of Rights Offering
FAQ
What was the purpose of the Rights Offering?
The filing does not specify the purpose of the Rights Offering, only that it has closed.
How much capital did IceCure Medical Ltd. raise from the Rights Offering?
The filing does not disclose the amount of capital raised in the Rights Offering.
What is the company's principal executive office address?
The company's principal executive office is located at 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
What is the Commission File Number for IceCure Medical Ltd.?
The Commission File Number for IceCure Medical Ltd. is 001-40753.
Is IceCure Medical Ltd. required to file annual reports under Form 20-F or Form 40-F?
IceCure Medical Ltd. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on August 1, 2025 regarding IceCure Medical Ltd. (ICCM).